Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 1 | Arthritis Res Ther

Figure 1

From: A model of inflammatory arthritis highlights a role for oncostatin M in pro-inflammatory cytokine-induced bone destruction via RANK/RANKL

Figure 1

Bone damage caused by oncostatin M (OSM) in combination with either IL-1 or tumour necrosis factor alpha (TNF-α) in murine joints. Adenovirus vectors overexpressing murine OSM, IL-1 or TNF-α were injected intra-articularly into the right knee joints of mice at 5 × 106 plaque-forming units [pfu]/vector/joint. The left knee joints were injected with the empty control vector. All joints received a total of 1 × 107 pfu/joint, and all animals were sacrificed at day 7 following administration. Sections (5 μm) were stained with H&E. (a) Control, (b) OSM, (c) IL-1, (d) TNF-α, (e), (f) OSM + IL-1, and (g), (h) OSM + TNF-α. The joints showed a moderate (b–d) to severe (e–h) synovial hyperplasia and an infiltration of inflammatory cells. Marked synovial hyperplasia with angiogenesis was also seen with bone erosions (arrows) and bone fractures, with evidence of synovial invasion (e and g). b, bone; bm, bone marrow; f, bone fracture; m, muscle; s, synovial cells; v, blood vessel. (a)–(e), (g) Bar = 50 μm; (f), (h) bar = 20 μm.

Back to article page